These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38925806)

  • 1. Optimizing Therapeutic Approaches in Superficial Esophageal Cancer: Reduced-volume Radiotherapy and Dose-dense Chemotherapy After Endoscopic Resection.
    Suzuki G; Yamazaki H; Aibe N; Masui K; Kimoto T; Nagasawa S; Kawabata K; Kajikawa T; Yoshino Y; Seri S; Asato A; Dohi O; Ishikawa T; Ogo E; Elsaleh H; Yamada K
    Anticancer Res; 2024 Jul; 44(7):3133-3139. PubMed ID: 38925806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoradiation versus surgery for superficial esophageal squamous cell carcinoma after noncurative endoscopic submucosal dissection: comparison of long-term oncologic outcomes.
    Suzuki G; Yamazaki H; Aibe N; Masui K; Kimoto T; Nagasawa S; Watanabe S; Seri S; Asato A; Shiozaki A; Fujiwara H; Konishi H; Dohi O; Ishikawa T; Elsaleh H; Yamada K
    Radiat Oncol; 2022 Nov; 17(1):191. PubMed ID: 36401267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additional chemoradiotherapy for superficial esophageal squamous cell carcinoma after near-circumferential or full-circumferential noncurative endoscopic submucosal dissection: a retrospective study.
    Tasaki Y; Yamazaki T; Miyazaki S; Takeda T; Nakatake M; Nakamura D; Takahira A; Honda K; Egawa A; Yamaguchi N; Nakao K; Toya R
    BMC Gastroenterol; 2024 Jul; 24(1):232. PubMed ID: 39044174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer.
    Kawaguchi G; Sasamoto R; Abe E; Ohta A; Sato H; Tanaka K; Maruyama K; Kaizu M; Ayukawa F; Yamana N; Liu J; Takeuchi M; Kobayashi M; Aoyama H
    Radiat Oncol; 2015 Jan; 10():31. PubMed ID: 25636830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer: choice of new approach.
    Suzuki G; Yamazaki H; Aibe N; Masui K; Sasaki N; Shimizu D; Kimoto T; Shiozaki A; Dohi O; Fujiwara H; Ishikawa T; Konishi H; Naito Y; Otsuji E; Yamada K
    Radiat Oncol; 2018 Dec; 13(1):246. PubMed ID: 30547811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
    Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H
    Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additional radiotherapy following endoscopic submucosal dissection for T1a-MM/T1b-SM esophageal squamous cell carcinoma improves locoregional control.
    Hisano O; Nonoshita T; Hirata H; Sasaki T; Watanabe H; Wakiyama H; Ono M; Ohga S; Honda H
    Radiat Oncol; 2018 Jan; 13(1):14. PubMed ID: 29378603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevant risk factors and prognostic impact of positive resection margins after endoscopic submucosal dissection of superficial esophageal squamous cell neoplasia.
    Wen J; Linghu E; Yang Y; Liu Q; Wang X; Du H; Wang H; Meng J; Lu Z
    Surg Endosc; 2014 May; 28(5):1653-9. PubMed ID: 24380990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of metachronous recurrence after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
    Uno K; Koike T; Kusaka G; Takahashi Y; Ara N; Shimosegawa T
    Dis Esophagus; 2017 Jun; 30(6):1-8. PubMed ID: 28475742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma.
    Chen J; Yin W; Yao H; Gu W
    Radiat Oncol; 2019 Sep; 14(1):169. PubMed ID: 31533757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the Charlson Comorbidity Index on the treatment strategy and survival in elderly patients after non-curative endoscopic submucosal dissection for esophageal squamous cell carcinoma: a multicenter retrospective study.
    Nakajo K; Abe S; Oda I; Ishihara R; Tanaka M; Yoshio T; Katada C; Yano T
    J Gastroenterol; 2019 Oct; 54(10):871-880. PubMed ID: 31055660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of radiation dose and predicted tumor invasion depth on local recurrence after definitive chemoradiotherapy for stage 0-I esophageal squamous cell carcinoma: a propensity score-weighted, retrospective, observational study.
    Ikawa T; Ishihara R; Matsueda K; Konishi K; Yamamoto S; Morimoto M; Kanayama N; Teshima T
    BMC Cancer; 2022 Mar; 22(1):301. PubMed ID: 35313853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short- and long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell cancer in patients with prior gastrectomy.
    Xu JQ; Hu JW; Chen WF; Xu MD; Zhong YS; Chen SY; Zhang YQ; Ma LL; Qin WZ; Cai MY; Yao LQ; Zhou PH; Li QL
    Surg Endosc; 2021 May; 35(5):2229-2239. PubMed ID: 32430528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic submucosal dissection under general anesthesia for superficial esophageal squamous cell carcinoma is associated with better clinical outcomes.
    Song BG; Min YW; Cha RR; Lee H; Min BH; Lee JH; Rhee PL; Kim JJ
    BMC Gastroenterol; 2018 Jun; 18(1):80. PubMed ID: 29879909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of salvage endoscopic submucosal dissection for local failure after chemoradiotherapy for esophageal squamous cell carcinoma.
    Kimura H; Yoshida M; Yabuuchi Y; Kakushima N; Yamamoto Y; Kawata N; Takizawa K; Kishida Y; Imai K; Ito S; Hotta K; Ishiwatari H; Matsubayashi H; Ono H
    Jpn J Clin Oncol; 2021 Jul; 51(7):1036-1043. PubMed ID: 33758950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up after endoscopic resection for superficial esophageal squamous cell carcinoma: a multicenter Western study.
    Berger A; Rahmi G; Perrod G; Pioche M; Canard JM; Cesbron-Métivier E; Boursier J; Samaha E; Vienne A; Lépilliez V; Cellier C
    Endoscopy; 2019 Apr; 51(4):298-306. PubMed ID: 30261535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of endoscopic mucosal resection as salvage treatment for patients with local failure after definitive chemoradiotherapy for stage IB, II, and III esophageal squamous cell cancer.
    Makazu M; Kato K; Takisawa H; Yoshinaga S; Oda I; Saito Y; Mayahara H; Ito Y; Itami J; Hamaguchi T; Yamada Y; Shimada Y
    Dis Esophagus; 2014 Jan; 27(1):42-9. PubMed ID: 23442160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome after endoscopic submucosal dissection in patients with superficial esophageal squamous cell carcinoma: a single-center study.
    Joo DC; Kim GH; Park DY; Jhi JH; Song GA
    Gut Liver; 2014 Nov; 8(6):612-8. PubMed ID: 25368748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic submucosal dissection versus surgery for T1b esophageal carcinoma: a single-center retrospective study.
    Zhang T; Wang H; Jin T; Wu Z; Li X; Zhang Q
    J Cancer Res Clin Oncol; 2024 May; 150(5):248. PubMed ID: 38724804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
    Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
    BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.